Higher HMOX1 activity is correlated with less frequent and less severe NAFLD (Raffaele et al., 2019; Severson et al., 2016), indicating that exercise was a therapeutic approach for NAFLD. Here, HMOX1 is linked to metabolic dysfunction-associated steatotic liver disease.